
US FDA approves Takeda's sleep disorder pill
来源:Reuters发布于 2026-08-05
The FDA has approved Takeda Pharmaceuticals' oral drug for narcolepsy, the U.S. health regulator said on Wednesday, backing the first treatment that targets all the symptoms of the rare sleep disord...
相关标的:TAK
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。